CD274 and colorectal carcinoma: Immunotherapy with PD‐1/PD‐L1 blockade has shown low response rates in CRC patients due to insensitivity or resistance, and the combination of immunotherapy with targeting therapy may yield unexpected outcomes.[35, 36] Thus, the graft tumor model of conditional processing was employed.